Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets
- 1 February 1992
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 45 (2) , 111-118
- https://doi.org/10.1016/0010-7824(92)90045-u
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiolContraception, 1990
- Hormonal and Nonhormonal Factors Affecting Sex Hormone‐Binding Globulin Levels in BloodAnnals of the New York Academy of Sciences, 1988
- Interactions of Contraceptive Steroids with Binding Proteins and the Clinical ImplicationsAnnals of the New York Academy of Sciences, 1988
- The pharmacokinetics of levonorgestrel and ethynylestradiol in women — Studies with ovran and ovranetteContraception, 1981
- Changes in Physiologically Free Circulating Estradiol and Testosterone during Exposure to Levonorgestrel*Journal of Clinical Endocrinology & Metabolism, 1981
- An investigation of the pharmacokinetics of ethynylestsadiol in women using badioimmunoassayContraception, 1979
- Investigations of pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in womenContraception, 1979
- Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in womenContraception, 1978
- Plasma levels of d-norgestrel after oral administrationContraception, 1976
- Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administrationContraception, 1975